Fundraising Fox
Spectrawave
Bedford, US · Founded 2017 · Delaware corporation · 24 employees on LinkedIn · 5 known investors
Find your way into Spectrawave
Sign up to see every warm intro you have to Spectrawave
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Spectrawave team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
SpectraWAVE develops optical and computational imaging technologies to diagnose and guide treatment decisions for patients with coronary artery disease and cardiovascular disease. The company operates vertically integrated design, manufacturing, and commercialization operations for its medical devices.
Founders & leadership
Spectrawave was founded in 2017 by Eman Namati, Guillermo Tearney, Gregg Stone, James Muller, and Jeffrey O'Donnell.
EN
Eman NamatiCo-founder · President, CEO, and Board Director2020–2026Eman Namati served as President & CEO of SpectraWAVE, where he led development of intravascular imaging and AI-enabled physiology technologies before the company's acquisition by Philips. Over two decades, he has held leadership roles in venture-backed medical device companies through product development, FDA clearance, and commercialization phases, and currently leads advanced imaging initiatives at Philips.
GT
Guillermo TearneyFounder; Professor of Pathology, Massachusetts General Hospital
GS
Gregg StoneFounder; Professor of Medicine, Mount Sinai Heart Health System
JM
James MullerFounder; Cardiologist, Brigham and Women's HospitalJames Muller is a cardiologist who held faculty positions at Harvard Medical School and Brigham and Women's Hospital and has over four decades of clinical and research experience in cardiology. He co-founded SpectraWAVE and previously co-founded InfraReDx, developing imaging technologies for coronary artery disease diagnosis and treatment.
JO
Jeffrey O'DonnellFounder; Managing General Partner, Runway Healthcare
VW
Vivek WalimbeChief Operating OfficerVivek Walimbe holds a PhD in Biomedical Engineering from Ohio State University and brings over 20 years of medical device experience across GE Healthcare, Medtronic, Baxter, and J&J MedTech, with roles spanning R&D leadership, product development, and regulatory affairs in imaging, therapy platforms, and AI-driven clinical solutions. At SpectraWAVE, he served as COO overseeing product development and commercialization before the company's acquisition by Philips.
BD
Brad DavisChief Commercial OfficerBrad Davis is Chief Commercial Officer of SpectraWAVE, which develops optical and computational imaging technologies for coronary artery and cardiovascular disease diagnosis. He brings over 25 years of medical device commercialization experience, including prior roles as first Chief Commercial Officer at OpSens Medical (which exited to Haemonetics) and senior commercial positions at Cardiovascular Systems, where he contributed to a $890 million acquisition by Abbott.
ES
Eric SwansonNamed on SEC filing
MS
Martin SeifertNamed on SEC filing
Board
PL
Investors · 5
Lumira Ventures✓ confirmed by SpectrawaveToronto · $1M – $10Mvia Gerry Brunk · board
How we know: Lumira Ventures's portfolio page · the company's own site · board seat on SEC Form D · Not right? Tell us
S3 Ventures✓ confirmed by SpectrawaveAustin · $500K – $15M
How we know: S3 Ventures's portfolio page · the company's own site · Not right? Tell us
SV Health Investors✓ confirmed by SpectrawaveLondon · $1M – $20Mvia Paul LaViolette · board
How we know: SV Health Investors's portfolio page · the company's own site · board seat on SEC Form D · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$66.7M disclosed across 2 rounds · 2019–2024
▶$50.3MraisedOct 2024 · 33 investors · OtherRule 506(b)
▶$50.3MraisedOct 2024 · 33 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Eman NamatiExecutive Officer, Director
- Paul LaVioletteDirector
- Gerry BrunkDirector
- Bill LittleDirector
- David NeustaedterDirector
- Brian SmithDirector
- Kadir KadhiresanDirector
- Offering amount
- $50.3M
- Amount sold
- $50.3M
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$16.4MraisedMay 2019 · 19 investors · OtherRule 506(b)
▶$16.4MraisedMay 2019 · 19 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Eric SwansonDirector
- Martin SeifertExecutive Officer, Director
- Steven HochbergDirector
- Guillermo TearneyDirector
- Offering amount
- $16.4M
- Amount sold
- $16.4M
- First sale
- May 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Spectrawave went on to found or lead other companies.
Related companies · 5
Boston ScientificBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
CqmedicalCQ Medical develops patient positioning and immobilization products used in radiation therapy, including devices for brachytherapy, SBRT, SRS, and proton treatments. Its offerings serve oncology and radiotherapy clinicians treating cancer and conditions such as osteoarthritis.
ItnonlineImaging Technology News is a trade publication that reaches over 34,000 radiology, radiation oncology, women's health, and nuclear medicine professionals with editorial content and product comparison tools. The publication serves as a primary resource for healthcare technology purchasing decisions within medical imaging specialties.
SonavexSonavex develops medical device technologies focused on vascular access and related clinical applications, drawing on ultrasound-based imaging and monitoring products. The company serves clinical and surgical care settings, particularly in the dialysis and renal care space.
Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Companies working in the same space as Spectrawave.
Frequently asked questions
- What does Spectrawave do?
- SpectraWAVE develops optical and computational imaging technologies to diagnose and guide treatment decisions for patients with coronary artery disease and cardiovascular disease. The company operates vertically integrated design, manufacturing, and commercialization operations for its medical devices.
- Who founded Spectrawave?
- Spectrawave was founded by Eman Namati, Guillermo Tearney, Gregg Stone, James Muller, Jeffrey O'Donnell in 2017.
- Who are Spectrawave's investors?
- Spectrawave's investors include Lumira Ventures, S3 Ventures, SV Health Investors, Deerfield Management Company, Johnson & Johnson Innovation – JJDC.
- How much funding has Spectrawave raised?
- Spectrawave has disclosed $66.7M raised across 2 rounds.
- Where is Spectrawave headquartered?
- Spectrawave is headquartered in Bedford, US.